Who is sponsoring NCT03864757?

NCT03864757 is sponsored by APrevent Biotech GmbH.

What drugs are being tested in NCT03864757?

Interventions in NCT03864757: thyroplasty implant.

What condition does NCT03864757 study?

NCT03864757 studies Paralysis, Unilateral, Vocal Cord.

Is NCT03864757 still recruiting?

NCT03864757 is currently completed. Last updated 7 March 2019.

Last reviewed 2019-03-07 · How we verify

NCT03864757

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

APrevent Vocal Implant System (VOIS) for Adjustable Treatment of Unilateral Vocal Fold Paralysis (UVFP)

Completed NA Last updated 7 March 2019

What this trial tests

NA trial testing thyroplasty implant in Paralysis, Unilateral, Vocal Cord in 8 participants. Completed in 21 February 2019.

Timeline

5 July 2018

Primary endpoint
21 February 2019

21 February 2019

Quick facts

Lead sponsor	APrevent Biotech GmbH
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	8
Start date	5 July 2018
Primary completion	21 February 2019
Estimated completion	21 February 2019
Sites	1 location across Austria

Drugs / interventions tested

thyroplasty implant

Conditions studied

Paralysis, Unilateral, Vocal Cord — all drugs for Paralysis, Unilateral, Vocal Cord →

Sponsor

APrevent Biotech GmbH

Who can join

Adults 18 to 80, any sex, with Paralysis, Unilateral, Vocal Cord. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate pre- and intraoperative voice quality, the degree of vocal fold closure and the Maximum Phonation Time (MPT), first determined after temporary APrevent® VOIS implantation and then after permanent existing product implantation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03864757 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by APrevent Biotech GmbH
Last refreshed: 7 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03864757.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing